Ethical considerations in CYP2D6 genotype testing for codeine-prescribed breastfeeding mothers

M. Kurtz; P. Black Golde; N. Berlinger

doi:10.1038/clpt.2010.225

Ethical considerations in CYP2D6 genotype testing for codeine-prescribed breastfeeding mothers

M. Kurtz, P. Black Golde, N. Berlinger

Research output: Contribution to journal › Comment/debate › peer-review

6 Scopus citations

Abstract

In this issue, Madadi et al. report on interviews with codeine-prescribed breastfeeding mothers concerning preferences and attitudes toward receiving their CYP2D6 genotype and overall study findings. We address three sets of ethics questions raised by this article. Should genetic information be disclosed to research participants in genetic research? What should clinicians take into account when considering this genetic test in managing infant opioid toxicity risk? What conditions support or hinder the integration of genetic information into patient care?

Original language	English (US)
Pages (from-to)	760-762
Number of pages	3
Journal	Clinical pharmacology and therapeutics
Volume	88
Issue number	6
DOIs	https://doi.org/10.1038/clpt.2010.225
State	Published - Dec 2010
Externally published	Yes

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1038/clpt.2010.225

Cite this

@article{80ab828ee9574757b55913cb8e2ba6aa,

title = "Ethical considerations in CYP2D6 genotype testing for codeine-prescribed breastfeeding mothers",

abstract = "In this issue, Madadi et al. report on interviews with codeine-prescribed breastfeeding mothers concerning preferences and attitudes toward receiving their CYP2D6 genotype and overall study findings. We address three sets of ethics questions raised by this article. Should genetic information be disclosed to research participants in genetic research? What should clinicians take into account when considering this genetic test in managing infant opioid toxicity risk? What conditions support or hinder the integration of genetic information into patient care?",

author = "M. Kurtz and {Black Golde}, P. and N. Berlinger",

year = "2010",

month = dec,

doi = "10.1038/clpt.2010.225",

language = "English (US)",

volume = "88",

pages = "760--762",

journal = "Clinical pharmacology and therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Ethical considerations in CYP2D6 genotype testing for codeine-prescribed breastfeeding mothers

AU - Kurtz, M.

AU - Black Golde, P.

AU - Berlinger, N.

PY - 2010/12

Y1 - 2010/12

N2 - In this issue, Madadi et al. report on interviews with codeine-prescribed breastfeeding mothers concerning preferences and attitudes toward receiving their CYP2D6 genotype and overall study findings. We address three sets of ethics questions raised by this article. Should genetic information be disclosed to research participants in genetic research? What should clinicians take into account when considering this genetic test in managing infant opioid toxicity risk? What conditions support or hinder the integration of genetic information into patient care?

AB - In this issue, Madadi et al. report on interviews with codeine-prescribed breastfeeding mothers concerning preferences and attitudes toward receiving their CYP2D6 genotype and overall study findings. We address three sets of ethics questions raised by this article. Should genetic information be disclosed to research participants in genetic research? What should clinicians take into account when considering this genetic test in managing infant opioid toxicity risk? What conditions support or hinder the integration of genetic information into patient care?

UR - http://www.scopus.com/inward/record.url?scp=78449296987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449296987&partnerID=8YFLogxK

U2 - 10.1038/clpt.2010.225

DO - 10.1038/clpt.2010.225

M3 - Comment/debate

C2 - 21081947

AN - SCOPUS:78449296987

SN - 0009-9236

VL - 88

SP - 760

EP - 762

JO - Clinical pharmacology and therapeutics

JF - Clinical pharmacology and therapeutics

IS - 6

ER -

Ethical considerations in CYP2D6 genotype testing for codeine-prescribed breastfeeding mothers

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this